Therefore, this study was mainly conducted to confirm that different components of BYHWT reduced blood lipid levels in hypercholesterolemia mouse model through the PPARγ/LXRα/ABCA1 pathway. This evidence concerns the gene NR1H3 and familial hypercholesterolemia.